Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.5.0.2
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Current assets:    
Cash $ 19,305 $ 7,857
Receivables 4,851 4,213
Prepaid expenses and other current assets 237 174
Total current assets 24,393 12,244
Property and equipment, net 905 1,043
Total assets 25,298 13,287
Current liabilities:    
Accounts payable 4,848 4,158
Accrued clinical trials expenses 771 341
Other accrued liabilities 449 354
Total current liabilities 6,068 4,853
Warrant liabilities 1,550 1,444
Total liabilities 7,618 6,297
Commitments and contingencies
Stockholders’ equity:    
Common stock, at amounts paid-in 297,855 297,828
Additional paid-in capital 23,842 23,261
Accumulated deficit (304,017) (314,099)
Total stockholders’ equity 17,680 6,990
Total liabilities and stockholders’ equity $ 25,298 $ 13,287